TABLE 2.
Differences in comorbidities for amlodipine and chlorthalidone
| Variables | Amlodipine (N = 281) | Chlorthalidone (N = 210) | p‐value |
|---|---|---|---|
| Atrial fibrillation | 9 (3.21%) | 4 (1.9%) | .543 |
| Angina | 11 (3.91%) | 3 (1.43%) | .173 |
| Myocardial infarction | 10 (3.56%) | 4 (1.9%) | .415 |
| Ulcer | 18 (6.41%) | 14 (6.67%) | 1 |
| Crohns | 6 (2.14%) | 4 (1.9%) | 1 |
| Diverticulitis | 20 (7.12%) | 9 (4.29%) | .261 |
| Gallbladder | 16 (5.69%) | 10 (4.76%) | .801 |
| Kidney infection | 33 (11.74%) | 21 (10%) | .642 |
| Benign prostatic hyperplasia | 46 (16.37%) | 31 (14.76%) | .719 |
| Osteoarthritis | 69 (24.64%) | 42 (20%) | .269 |
| Rheumatoid arthritis | 24 (8.54%) | 13 (6.19%) | .422 |
| Gout | 28 (9.96%) | 11 (5.24%) | .081 |
| Peripheral vascular disease | 9 (3.2%) | 4 (1.9%) | .547 |
| Transient ischemic attack | 6 (2.14%) | 1 (0.48%) | .25 |
| Anemia | 40 (14.23%) | 22 (10.48%) | .27 |
| Low back pain | 119 (42.35%) | 75 (35.71%) | .163 |
| Cataracts | 83 (29.54%) | 50 (23.81%) | .19 |
| Depression | 59 (21%) | 44 (21.05%) | 1 |
| Anxiety | 22 (7.83%) | 19 (9.05%) | .751 |